All In Biotech

Drug Trial Radar · NCT02426905

Study to Assess Long-Term Outcomes of Trientine in Wilson Disease Patients Withdrawn From Therapy With d-Penicillamine

Multicentre, Retrospective and Prospective Study to Assess Long-Term Outcomes of Chelator-Based Treatment With Trientine in Wilson Disease Patients Withdrawn From Therapy With d-Penicillamine

Last checked: Nov 20, 2026Latest source record: Aug 23, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

90

Planned (sponsor's estimate)

Start

Jan 2016

Primary completion

May 2018

Study completion Jul 2018

Sponsor

Lead sponsor
Univar BVIndustry
Sponsor type
Industry
First posted
Apr 27, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 1 year, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A study to review Wilson disease patients who have previously been prescribed d- Penicillamine but were changed to trientine as treatment for their disease, and to follow them for a further 12 months.

Conditions

  • Wilson Disease

Interventions

  • trientine dihydrochlorideDrug

    A retrospective review of patients' medical records

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical outcome specific to the retrospective part of the studyTime frame: 48 months
  2. Clinical outcome specific to the prospective part of the studyTime frame: 12 months

Locations

4 sites in 4 countries. Site status is shown where the registry gives one.

  • Universitätsklinik Heidelberg

    Heidelberg, Germany

  • "Aghia Sophia" Children's Hospital

    Goudi, Greece

  • San Paolo Hospital UOC

    Milan, Italy

  • Kings College Hospital

    London, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.